
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $19B | $20.4B | $19.3B | $19.7B | $19.4B | |
Revenue Growth (YoY) | -0.89% | 7.27% | -5.51% | 2.49% | -1.56% | |
Cost of Revenues | $12B | $12.6B | $12.2B | $12.6B | $12.2B | |
Gross Profit | $7B | $7.8B | $7.1B | $7.1B | $7.3B | |
Gross Profit Margin | 36.72% | 38.14% | 36.71% | 36.07% | 37.34% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.4B | $5.8B | $5.2B | $5.2B | $5.4B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $5.7B | $5.8B | $5.4B | $5.4B | $5.5B | |
Operating Income | $1.3B | $1.9B | $1.7B | $1.7B | $1.8B | |
Net Interest Expenses | $72.6M | $116.3M | $89.9M | $28.5M | $17.3M | |
EBT. Incl. Unusual Items | $1.2B | $1.8B | $1.6B | $1.7B | $1.8B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $307.4M | $419.3M | $416.2M | $540.5M | $487.8M | |
Net Income to Company | $1.2B | $1.8B | $1.6B | $1.7B | $1.8B | |
Minority Interest in Earnings | $2.3M | -$2.9M | -$1.2M | -$13.9M | -$7.3M | |
Net Income to Common Excl Extra Items | $869.7M | $1.4B | $1.2B | $1.2B | $1.3B | |
Basic EPS (Cont. Ops) | $0.61 | $0.92 | $0.76 | $0.77 | $0.84 | |
Diluted EPS (Cont. Ops) | $0.61 | $0.92 | $0.76 | $0.77 | $0.84 | |
Weighted Average Basic Share | $1.4B | $1.5B | $1.5B | $506.7M | $1.5B | |
Weighted Average Diluted Share | $1.4B | $1.5B | $1.5B | $1.5B | $1.5B | |
EBITDA | $2.5B | $3.2B | $2.8B | $2.9B | $2.9B | |
EBIT | $1.3B | $2B | $1.7B | $1.9B | $1.9B | |
Revenue (Reported) | $19B | $20.4B | $19.3B | $19.7B | $19.4B | |
Operating Income (Reported) | $1.3B | $1.9B | $1.7B | $1.7B | $1.8B | |
Operating Income (Adjusted) | $1.3B | $2B | $1.7B | $1.9B | $1.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $4.3B | $4.3B | $4.2B | $4.2B | $4.1B | |
Revenue Growth (YoY) | 14.77% | -0.81% | -1.52% | -1.36% | -22.44% | |
Cost of Revenues | $2.7B | $2.7B | $2.8B | $2.7B | $2.7B | |
Gross Profit | $1.6B | $1.5B | $1.5B | $1.5B | $1.5B | |
Gross Profit Margin | 37.82% | 35.78% | 34.57% | 35.18% | 35.37% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.4B | $1.3B | $1.2B | $1.2B | $1.2B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.1B | $1.5B | $1.2B | $1.2B | $1.2B | |
Operating Income | $493.2M | $77.8M | $242.4M | $219.4M | $222.6M | |
Net Interest Expenses | $32.3M | $13.8M | $25.8M | $6.5M | $12.8M | |
EBT. Incl. Unusual Items | $461.6M | $64.8M | $216.5M | $212.1M | $208.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $149.7M | $27.3M | $65.3M | $47M | $66.2M | |
Net Income to Company | $461.6M | $64.8M | $216.5M | $212.1M | $208.6M | |
Minority Interest in Earnings | $1.5M | -$103.3K | -$83.3K | -$4.6M | -$1.2M | |
Net Income to Common Excl Extra Items | $313.4M | $37.4M | $151.2M | $160.6M | $141.1M | |
Basic EPS (Cont. Ops) | $0.21 | $0.02 | $0.10 | $0.11 | $0.09 | |
Diluted EPS (Cont. Ops) | $0.21 | $0.02 | $0.10 | $0.11 | $0.09 | |
Weighted Average Basic Share | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | |
Weighted Average Diluted Share | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | |
EBITDA | $813.2M | $385M | $526.4M | $511.6M | $523.1M | |
EBIT | $501M | $95.1M | $258.5M | $246.6M | $269.5M | |
Revenue (Reported) | $4.3B | $4.3B | $4.2B | $4.2B | $4.1B | |
Operating Income (Reported) | $493.2M | $77.8M | $242.4M | $219.4M | $222.6M | |
Operating Income (Adjusted) | $501M | $95.1M | $258.5M | $246.6M | $269.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $19.6B | $20.3B | $19B | $19.6B | $18.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $12.3B | $12.6B | $12.1B | $12.5B | $11.7B | |
Gross Profit | $7.3B | $7.7B | $6.9B | $7.1B | $6.6B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.6B | $5.7B | $5.1B | $5.2B | $5.1B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $5.6B | $6.1B | $5.1B | $5.4B | $5.3B | |
Operating Income | $1.6B | $1.5B | $1.8B | $1.7B | $1.3B | |
Net Interest Expenses | $72.9M | $97.3M | $99.2M | $10.9M | $12.4M | |
EBT. Incl. Unusual Items | $1.6B | $1.4B | $1.7B | $1.7B | $1.3B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $447M | $299.9M | $442.1M | $515.1M | $401.5M | |
Net Income to Company | $1.5B | $1.4B | $1.7B | $1.7B | $1.3B | |
Minority Interest in Earnings | $3.3M | -$4.4M | -$1.2M | -$18M | -$11.4M | |
Net Income to Common Excl Extra Items | $1.1B | $1.1B | $1.2B | $1.2B | $848.9M | |
Basic EPS (Cont. Ops) | $0.76 | $0.74 | $0.81 | $0.77 | $0.56 | |
Diluted EPS (Cont. Ops) | $0.76 | $0.74 | $0.81 | $0.77 | $0.56 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $2.9B | $2.8B | $2.9B | $2.9B | $2.4B | |
EBIT | $1.7B | $1.6B | $1.8B | $1.8B | $1.4B | |
Revenue (Reported) | $19.6B | $20.3B | $19B | $19.6B | $18.2B | |
Operating Income (Reported) | $1.6B | $1.5B | $1.8B | $1.7B | $1.3B | |
Operating Income (Adjusted) | $1.7B | $1.6B | $1.8B | $1.8B | $1.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $4.3B | $4.3B | $4.2B | $4.2B | $4.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.7B | $2.7B | $2.8B | $2.7B | $2.7B | |
Gross Profit | $1.6B | $1.5B | $1.5B | $1.5B | $1.5B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.4B | $1.3B | $1.2B | $1.2B | $1.2B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.1B | $1.5B | $1.2B | $1.2B | $1.2B | |
Operating Income | $493.2M | $77.8M | $242.4M | $219.4M | $222.6M | |
Net Interest Expenses | $32.3M | $13.8M | $25.8M | $6.5M | $12.8M | |
EBT. Incl. Unusual Items | $461.6M | $64.8M | $216.5M | $212.1M | $208.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $149.7M | $27.3M | $65.3M | $47M | $66.2M | |
Net Income to Company | $461.6M | $64.8M | $216.5M | $212.1M | $208.6M | |
Minority Interest in Earnings | $1.5M | -$103.3K | -$83.3K | -$4.6M | -$1.2M | |
Net Income to Common Excl Extra Items | $313.4M | $37.4M | $151.2M | $160.6M | $141.1M | |
Basic EPS (Cont. Ops) | $0.21 | $0.02 | $0.10 | $0.11 | $0.09 | |
Diluted EPS (Cont. Ops) | $0.21 | $0.02 | $0.10 | $0.11 | $0.09 | |
Weighted Average Basic Share | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | |
Weighted Average Diluted Share | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | |
EBITDA | $813.2M | $385M | $526.4M | $511.6M | $523.1M | |
EBIT | $501M | $95.1M | $258.5M | $246.6M | $269.5M | |
Revenue (Reported) | $4.3B | $4.3B | $4.2B | $4.2B | $4.1B | |
Operating Income (Reported) | $493.2M | $77.8M | $242.4M | $219.4M | $222.6M | |
Operating Income (Adjusted) | $501M | $95.1M | $258.5M | $246.6M | $269.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $469.9M | $458.3M | $285.5M | $425.1M | $534.7M | |
Short Term Investments | $41M | $61.9M | $76.5M | $74.2M | $108.8M | |
Accounts Receivable, Net | $3.7B | $3.4B | $3.2B | $3.3B | $2.8B | |
Inventory | $1.8B | $1.7B | $1.8B | $1.9B | $1.7B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $312.7M | $296.2M | $244.6M | $288.3M | $256.3M | |
Total Current Assets | $6.7B | $6.1B | $5.6B | $6B | $5.5B | |
Property Plant And Equipment | $7.9B | $7.1B | $6.4B | $6.3B | $6B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $250.6M | $157.1M | $143.2M | $139.2M | $100M | |
Total Assets | $43B | $39.5B | $36.8B | $37.5B | $34.4B | |
Accounts Payable | $4.6B | $4.6B | $4.5B | $5.1B | $4.6B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $1.1B | $1.1B | $959.6M | $957.2M | $955.3M | |
Total Current Liabilities | $16B | $10.8B | $9.7B | $9.9B | $9.6B | |
Long-Term Debt | $8.7B | $10.2B | $8.6B | $7.2B | $5.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $28.3B | $24.2B | $21.1B | $20B | $17.4B | |
Common Stock | $2.1B | $1.9B | $1.7B | $1.6B | $1.4B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $14.7B | $15.3B | $15.7B | $17.4B | $17B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $16.4M | $17.8M | $16.9M | $37.1M | $33.4M | |
Total Equity | $14.7B | $15.3B | $15.7B | $17.5B | $17B | |
Total Liabilities and Equity | $43B | $39.5B | $36.8B | $37.5B | $34.4B | |
Cash and Short Terms | $510.8M | $520.2M | $362M | $499.3M | $643.4M | |
Total Debt | $17.7B | $13.9B | $11.4B | $10B | $8.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $473.5M | $372.8M | $318.8M | $438.8M | $460.6M | |
Short Term Investments | $50.6M | $98.8M | $70.7M | $70.4M | $87.9M | |
Accounts Receivable, Net | $2.8B | $2.9B | $2.9B | $2.9B | $2.8B | |
Inventory | $1.8B | $1.9B | $2B | $1.9B | $1.9B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $356M | $309.6M | $322.7M | $274.1M | $320.1M | |
Total Current Assets | $5.7B | $5.8B | $5.6B | $5.6B | $5.6B | |
Property Plant And Equipment | $7.4B | $6.7B | $6.3B | $6B | $6.1B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $209.7M | $186.1M | $140.5M | $118.9M | $185.7M | |
Total Assets | $40.9B | $39.2B | $36.8B | $35.7B | $35.2B | |
Accounts Payable | $4B | $4.2B | $4.1B | $4.2B | $4B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $843.8M | $881.5M | $808.9M | $767.4M | $846.9M | |
Total Current Liabilities | $11.9B | $10.5B | $9.4B | $9.6B | $10.6B | |
Long-Term Debt | $10.5B | $9.6B | $8.8B | $6.7B | $5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $25.9B | $23.2B | $21B | $19B | $18.2B | |
Common Stock | $2B | $1.8B | $1.7B | $1.5B | $1.5B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $14M | $17.4M | $16.7M | $32.5M | $26.5M | |
Total Equity | $15B | $16B | $15.8B | $16.7B | $17B | |
Total Liabilities and Equity | $40.9B | $39.2B | $36.8B | $35.7B | $35.2B | |
Cash and Short Terms | $524.2M | $471.6M | $389.6M | $509.1M | $548.5M | |
Total Debt | $16.4B | $13.8B | $12.4B | $10.5B | $10.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.2B | $1.8B | $1.6B | $1.7B | $1.8B | |
Depreciation & Amoritzation | $1.2B | $1.2B | $1.1B | $1.1B | $1B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $455.9M | -$107.7M | -$6.3M | -$168.3M | $258.2M | |
Change in Inventories | $31M | -$132.8M | -$214.4M | -$174.2M | $10.2M | |
Cash From Operations | $2.6B | $3.1B | $2B | $2.5B | $2.7B | |
Capital Expenditures | $850.2M | $844.3M | $765.7M | $782.8M | $900.6M | |
Cash Acquisitions | -$10.9B | -$130.9M | -$33.3M | -$157.7M | -$138.6M | |
Cash From Investing | -$11.6B | -$130.8M | -$530.6M | -$839M | -$784.3M | |
Dividends Paid (Ex Special Dividend) | -$433.5M | -$494.2M | -$427.4M | -$411.7M | -$438.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $5.7B | $4.3B | $460.1M | $1.1B | $1.6B | |
Long-Term Debt Repaid | -$2.1B | -$2.5B | -$1.5B | -$1B | -$2.5B | |
Repurchase of Common Stock | -$2.9M | -$237K | -$2M | -$178.2K | -$198.4M | |
Other Financing Activities | -$32.2M | -$10.2M | -$2M | $351.8M | $105.2M | |
Cash From Financing | $9B | -$2.9B | -$1.7B | -$1.6B | -$1.8B | |
Beginning Cash (CF) | $454.3M | $441.7M | $404.5M | $266.8M | $396.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$100.8M | $28.6M | -$174.5M | $22M | $81.1M | |
Ending Cash (CF) | $454M | $480.7M | $287.1M | $427.3M | $555M | |
Levered Free Cash Flow | $1.7B | $2.2B | $1.3B | $1.7B | $1.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $461.6M | $64.8M | $216.5M | $212.1M | $208.6M | |
Depreciation & Amoritzation | $312.2M | $289.9M | $267.9M | $265.1M | $253.6M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $732.9M | $477.2M | $227.6M | $217.1M | $61.4M | |
Change in Inventories | -$142.5M | -$205.6M | -$189.4M | -$61.9M | -$115.7M | |
Cash From Operations | $194.5M | -$201.2M | -$368.7M | -$424.3M | -$993.7M | |
Capital Expenditures | $209.2M | $194M | $200.8M | $227.9M | $253.7M | |
Cash Acquisitions | -- | -- | -$167.5M | -$133.2M | -$38.4M | |
Cash From Investing | $372M | -$150.7M | -$335.4M | -$352M | -$282.6M | |
Dividends Paid (Ex Special Dividend) | -$253.6M | -$239.9M | -$222.5M | -$221.9M | -$266.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2.7B | -- | $757.1M | -- | $327.9M | |
Long-Term Debt Repaid | -$48.4M | -$180.6M | -$143.8M | -$464.1M | -$123.8M | |
Repurchase of Common Stock | -$28.3K | -$17.2K | -$15.1K | -$40.4K | -$6.6K | |
Other Financing Activities | -$3.8M | -$137.7K | -$3M | -$53.9K | -$511.5K | |
Cash From Financing | -$588.2M | $259M | $747.4M | $754.9M | $1.2B | |
Beginning Cash (CF) | $457.6M | $454M | $283.4M | $403.9M | $550.6M | |
Foreign Exchange Rate Adjustment | $57.4M | $30.5M | -$757.1K | $64.9M | -$46.8M | |
Additions / Reductions | -$21.7M | -$92.9M | $43.4M | -$21.4M | -$51.9M | |
Ending Cash (CF) | $493.2M | $391.6M | $321.6M | $447.4M | $452M | |
Levered Free Cash Flow | -$14.7M | -$395.2M | -$569.4M | -$652.1M | -$1.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.5B | $1.4B | $1.7B | $1.7B | $1.3B | |
Depreciation & Amoritzation | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $261M | -$363.4M | -$255.9M | -$178.8M | $181.1M | |
Change in Inventories | $1.3M | -$195.9M | -$198.1M | -$46.7M | -$144.2M | |
Cash From Operations | $2.7B | $2.7B | $1.9B | $2.4B | $358.9M | |
Capital Expenditures | $858.8M | $829.1M | $772.5M | $809.9M | $785.9M | |
Cash Acquisitions | -$10.9B | -$130.9M | -$200.8M | -$123.4M | -$305.6M | |
Cash From Investing | -$11B | -$653.4M | -$715.3M | -$855.6M | -$1B | |
Dividends Paid (Ex Special Dividend) | -$485.1M | -$480.5M | -$410M | -$411.1M | -$489.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $1.6B | $1.2B | $312M | $1.1B | |
Long-Term Debt Repaid | -$2.2B | -$2.6B | -$1.4B | -$1.3B | -$2.3B | |
Repurchase of Common Stock | -$2.9M | -$225.9K | -$2M | -$203.5K | -$164.8K | |
Other Financing Activities | -$35.7M | -$6.6M | -$4.8M | $354.7M | $343.2M | |
Cash From Financing | $8.1B | -$2.1B | -$1.2B | -$1.6B | $172.7M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$234.3M | -$42.6M | -$38.3M | -$42.7M | -$490M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $1.9B | $1.9B | $1.1B | $1.6B | -$426.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $461.6M | $64.8M | $216.5M | $212.1M | $208.6M | |
Depreciation & Amoritzation | $312.2M | $289.9M | $267.9M | $265.1M | $253.6M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $732.9M | $477.2M | $227.6M | $217.1M | $61.4M | |
Change in Inventories | -$142.5M | -$205.6M | -$189.4M | -$61.9M | -$115.7M | |
Cash From Operations | $194.5M | -$201.2M | -$368.7M | -$424.3M | -$993.7M | |
Capital Expenditures | $209.2M | $194M | $200.8M | $227.9M | $253.7M | |
Cash Acquisitions | -- | -- | -$167.5M | -$133.2M | -$38.4M | |
Cash From Investing | $372M | -$150.7M | -$335.4M | -$352M | -$282.6M | |
Dividends Paid (Ex Special Dividend) | -$253.6M | -$239.9M | -$222.5M | -$221.9M | -$266.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2.7B | -- | $757.1M | -- | $327.9M | |
Long-Term Debt Repaid | -$48.4M | -$180.6M | -$143.8M | -$464.1M | -$123.8M | |
Repurchase of Common Stock | -$28.3K | -$17.2K | -$15.1K | -$40.4K | -$6.6K | |
Other Financing Activities | -$3.8M | -$137.7K | -$3M | -$53.9K | -$511.5K | |
Cash From Financing | -$588.2M | $259M | $747.4M | $754.9M | $1.2B | |
Beginning Cash (CF) | $457.6M | $454M | $283.4M | $403.9M | $550.6M | |
Foreign Exchange Rate Adjustment | $57.4M | $30.5M | -$757.1K | $64.9M | -$46.8M | |
Additions / Reductions | -$21.7M | -$92.9M | $43.4M | -$21.4M | -$51.9M | |
Ending Cash (CF) | $493.2M | $391.6M | $321.6M | $447.4M | $452M | |
Levered Free Cash Flow | -$14.7M | -$395.2M | -$569.4M | -$652.1M | -$1.2B |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.